Current Value of Holding

$2.6 Million

Shares

22 Thousand

% of Portfolio

0.03%

Average Buy Price

$222

Avg closing price
Price range

43 Paul Tudor Jones II Biogen Trades

Paul Tudor Jones II acquired 39.5 Thousand Biogen shares worth $4.67 Million. That's 0.06% of their equity portfolio (419th largest holding). The first Biogen trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 31 more times and sold shares on 23 occasions. The investor's estimated purchase price is $6.77 Million, resulting in a loss of 31%.

Avg closing price
Price range
Sold 59.0% shares (-31.7 Thousand shares) Q4 2024
Avg closing price $167.98
Price range $146.06 - $191.56
Increased shares by 519.6% (+45 Thousand shares) Q3 2024
Avg closing price $209.38
Price range $189.07 - $236.80
Sold 80.8% shares (-36.4 Thousand shares) Q2 2024
Avg closing price $217.32
Price range $190.52 - $236.72
New holding (+45 Thousand shares) Q1 2024
Avg closing price $234.20
Price range $212.02 - $267.71
Sold -5 Thousand shares Q1 2023
Avg closing price $276.70
Price range $256.56 - $292.34
Sold 47.7% shares (-4.55 Thousand shares) Q4 2022
Avg closing price $282.44
Price range $253.67 - $306.72
Increased shares by 450.7% (+7.81 Thousand shares) Q3 2022
Avg closing price $212.38
Price range $194.69 - $276.61
Sold 65.3% shares (-3.26 Thousand shares) Q2 2022
Avg closing price $204.43
Price range $187.54 - $223.02
New holding (+4.99 Thousand shares) Q1 2022
Avg closing price $217.46
Price range $193.77 - $244.14
Sold -8.6 Thousand shares Q4 2021
Avg closing price $257.12
Price range $223.92 - $287.77
Increased shares by 115.5% (+4.61 Thousand shares) Q3 2021
Avg closing price $327.75
Price range $282.99 - $369.05
New holding (+3.99 Thousand shares) Q2 2021
Avg closing price $302.94
Price range $259.00 - $414.71
Sold -3.44 Thousand shares Q1 2021
Avg closing price $269.69
Price range $242.95 - $284.63
New holding (+3.44 Thousand shares) Q4 2020
Avg closing price $257.97
Price range $236.26 - $355.63
Sold -4.82 Thousand shares Q3 2020
Avg closing price $278.91
Price range $264.77 - $305.71
Increased shares by 11.1% (+482 shares) Q2 2020
Avg closing price $300.59
Price range $258.66 - $342.55
Increased shares by 15.7% (+590 shares) Q1 2020
Avg closing price $303.47
Price range $268.85 - $341.04
Sold 92.9% shares (-48.9 Thousand shares) Q4 2019
Avg closing price $277.46
Price range $220.06 - $304.07
Increased shares by 57.5% (+19.2 Thousand shares) Q3 2019
Avg closing price $232.85
Price range $217.44 - $243.88
Sold 17.1% shares (-6.87 Thousand shares) Q2 2019
Avg closing price $230.90
Price range $219.29 - $241.72

News about Biogen Inc and Paul Tudor Jones II

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!